TLI Logo

Home Profiles Jerome I. Rotter, MD, FACP, FACMG, FAHA

Investigator, Translational Genomics
Distinguished Professor of Pediatrics and Human Genetics, David Geffen School of Medicine at UCLA
Executive Data Science Officer, The Lundquist Institute

Jerome I. Rotter, MD, FACP, FACMG, FAHA

Research Areas

, ,
Research

Dr. Rotter’s research is in the genetics of common, complex diseases, those disorders that contribute to the major morbidity and mortality of the U.S. population. His work has utilized a variety of paradigms, from family-based, to case-control, to cohort, to pharmacogenetic studies, and from subclinical phenotypes, to candidate gene, to family based linkage, to genome-wide association, to large scale genome-wide genotyping and sequencing, to whole exome and whole genome sequencing, and to multi-omics.

He has contributed to our knowledge of the genetic basis of diabetes and insulin resistance, of blood pressure and hypertension, of lipid disorders and coronary artery disease, of cardiac rhythm disorders and sudden cardiac death, of obesity and fatty liver, and diabetic retinopathy, glaucoma, and retinopathy of prematurity, in multiple ethnic groups. The many genetic loci (chromosomal regions) identified are being utilized to generate multi-loci polygenic risk scores as tools to dissect disease etiology and to perform risk assessment in diverse populations and ethnic groups.

The ultimate goal of this work is to identify the optimal therapy and prevention for cardio metabolic, neurologic, and ocular disorders as a function of an individual’s genetic predispositions. Thus, this is the basis for precision/personalized medicine, especially in multi-ethnic populations that comprise the tapestry of the United States.

Biography

Jerome I. Rotter, M.D., F.A.C.P., F.A.C.M.G., F.A.H.A., is a medical geneticist/genetic epidemiologist. He is Director of the Institute for Translational Genomics and Population Sciences at the Lundquist Institute for Biomedical Innovation (formerly the Los Angeles Biomedical Research Institute) at Harbor-UCLA, Director of the Division of Genomic Outcomes in the Department of Pediatrics and Medicine, Harbor UCLA Medical Center (the southern campus of the UCLA School of Medicine), and a Distinguished Professor of Pediatrics and Human Genetics at UCLA.

He is a recipient of the Legends of Harbor-UCLA Medical Center Award, the Cedars-Sinai Pioneer in Medicine Award, the CHARGE Senior Leadership Award, and election to the CHARGE Hall of Fame. Dr. Rotter serves on the Steering Committees of major programs and consortia investigating the genomics of common cardio metabolic diseases, including TOPMed (NHLBI’s Trans-Omics for Precision Medicine), CHARGE (Cohorts for Heart and Aging Research in Genomic Epidemiology), MESA (NHLBI’s Multi-Ethnic Study of Atherosclerosis, Chair, Genetics Committee), and DEFINE-T2D (NIDDK’s T2D Heterogeneity Consortium).

Publications

The following is a selected number of articles in 12 disease areas of the Genomics of Common Diseases actively studied by members of the Center for Translational Genomics.

Diabetes Mellitus (includes Type 1 DM, Type 2DM, Insulin Resistance, Insulin Secretion, Insulin Clearance, Fasting Glucose, Fasting Insulin, HgbA1C, and Diabetic Nephropathy)
Cardiovascular Disease (includes CAD, Subclinical Atherosclerosis, Stroke, and Valvular Disease)
Ocular Disorders (includes Diabetic Retinopathy, Keratoconus, Macular Degeneration, Glaucoma, and Retinal Vasculature)
Lipids (includes LDL, HDL, TG, Lp(a))
Blood Pressure and Hypertension 
EKG and Arrhythmias (includes Atrial Fibrillation and Sudden Cardiac Death)
Pharmacogenetics
Anthropometry (includes Adiposity, Height)
Fatty Liver (Metabolic Associated Steatotic Liver Disease)
Alzheimer’s (includes Cognition, Dementia)
Sleep and Circadian Misalignment 
Gene by Environment (Includes Diet, Alcohol, Smoking, Physical Education, Air Pollution)